BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 19775664)

  • 1. Epigenetic information in chromatin and cancer.
    Herceg Z
    Eur J Cancer; 2009 Sep; 45 Suppl 1():442-4. PubMed ID: 19775664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic information in chromatin: the code of entry for DNA repair.
    Loizou JI; Murr R; Finkbeiner MG; Sawan C; Wang ZQ; Herceg Z
    Cell Cycle; 2006 Apr; 5(7):696-701. PubMed ID: 16582631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epigenetic code for DNA damage repair pathways?
    Hassa PO; Hottiger MO
    Biochem Cell Biol; 2005 Jun; 83(3):270-85. PubMed ID: 15959555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What histone code for DNA repair?
    Escargueil AE; Soares DG; Salvador M; Larsen AK; Henriques JA
    Mutat Res; 2008; 658(3):259-70. PubMed ID: 18296106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the double helix: writing and reading the histone code.
    Wang Y; Fischle W; Cheung W; Jacobs S; Khorasanizadeh S; Allis CD
    Novartis Found Symp; 2004; 259():3-17; discussion 17-21, 163-9. PubMed ID: 15171244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone H2A ubiquitination in transcriptional regulation and DNA damage repair.
    Zhou W; Wang X; Rosenfeld MG
    Int J Biochem Cell Biol; 2009 Jan; 41(1):12-5. PubMed ID: 18929679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Setting and resetting of epigenetic marks in malignant transformation and development.
    Richly H; Lange M; Simboeck E; Di Croce L
    Bioessays; 2010 Aug; 32(8):669-79. PubMed ID: 20658705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone modification: cause or cog?
    Henikoff S; Shilatifard A
    Trends Genet; 2011 Oct; 27(10):389-96. PubMed ID: 21764166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone onco-modifications.
    Füllgrabe J; Kavanagh E; Joseph B
    Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone acetylation and methylation: combinatorial players for transcriptional regulation.
    An W
    Subcell Biochem; 2007; 41():351-69. PubMed ID: 17484136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylomes, histone codes and miRNAs: tying it all together.
    Guil S; Esteller M
    Int J Biochem Cell Biol; 2009 Jan; 41(1):87-95. PubMed ID: 18834952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of epigenetic inheritance.
    Martin C; Zhang Y
    Curr Opin Cell Biol; 2007 Jun; 19(3):266-72. PubMed ID: 17466502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?
    Geiman TM; Robertson KD
    J Cell Biochem; 2002; 87(2):117-25. PubMed ID: 12244565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chromatin epigenetic modifications in cancer generation].
    Arenas-Huertero F; Recillas-Targa F
    Gac Med Mex; 2002; 138(6):547-55. PubMed ID: 12532619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics and cancer: implications for drug discovery and safety assessment.
    Moggs JG; Goodman JI; Trosko JE; Roberts RA
    Toxicol Appl Pharmacol; 2004 May; 196(3):422-30. PubMed ID: 15094313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.